IDEAYA Biosciences, Inc. financial data

Symbol
IDYA on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1247% % -38%
Debt-to-equity 8.2% % 76%
Return On Equity -11% % 58%
Return On Assets -10% % 60%
Operating Margin -4671% % -713%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 87,814,027 shares 0.32%
Common Stock, Shares, Outstanding 87,796,561 shares 1.5%
Entity Public Float $1,800,000,000 USD -33%
Common Stock, Value, Issued $9,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 88,485,238 shares 8.3%
Weighted Average Number of Shares Outstanding, Diluted 88,485,238 shares 8.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $207,834,000 USD
Research and Development Expense $314,704,000 USD 6.8%
General and Administrative Expense $63,319,000 USD 61%
Operating Income (Loss) $159,313,000 USD 51%
Nonoperating Income (Expense) $45,615,000 USD -13%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $113,698,000 USD 59%
Earnings Per Share, Basic -1.28 USD/shares 62%
Earnings Per Share, Diluted -1.28 USD/shares 62%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $112,825,000 USD 34%
Marketable Securities, Current $526,563,000 USD -11%
Assets, Current $666,727,000 USD -3.3%
Property, Plant and Equipment, Net $8,217,000 USD -8.4%
Operating Lease, Right-of-Use Asset $23,068,000 USD 23%
Other Assets, Noncurrent $75,000 USD -31%
Assets $1,109,324,000 USD -1.3%
Accounts Payable, Current $17,584,000 USD 14%
Employee-related Liabilities, Current $11,198,000 USD 36%
Accrued Liabilities, Current $40,892,000 USD 35%
Contract with Customer, Liability, Current $490,000 USD
Liabilities, Current $58,815,000 USD 28%
Contract with Customer, Liability, Noncurrent $1,676,000 USD
Operating Lease, Liability, Noncurrent $27,575,000 USD 46%
Liabilities $86,390,000 USD 33%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,267,000 USD 179%
Retained Earnings (Accumulated Deficit) $736,539,000 USD -18%
Stockholders' Equity Attributable to Parent $1,022,934,000 USD -3.4%
Liabilities and Equity $1,109,324,000 USD -1.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $60,342,000 USD -38%
Net Cash Provided by (Used in) Financing Activities $26,143,000 USD -93%
Net Cash Provided by (Used in) Investing Activities $79,817,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 87,796,561 shares 1.5%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $45,618,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $113,840,000 USD 34%
Interest Paid, Excluding Capitalized Interest, Operating Activities $12,000 USD -7.7%
Deferred Tax Assets, Valuation Allowance $196,405,000 USD 19%
Deferred Tax Assets, Gross $201,341,000 USD 19%
Operating Lease, Liability $27,914,000 USD 46%
Payments to Acquire Property, Plant, and Equipment $1,330,000 USD 0.38%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $112,243,000 USD 59%
Lessee, Operating Lease, Liability, to be Paid $46,358,000 USD 23%
Property, Plant and Equipment, Gross $22,473,000 USD 8.7%
Operating Lease, Liability, Current $339,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,379,000 USD 215%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,944,000 USD 404%
Operating Lease, Weighted Average Discount Rate, Percent 0.115 pure -8.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18,444,000 USD -0.76%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,248,000 USD 20%
Deferred Tax Assets, Operating Loss Carryforwards $37,207,000 USD -0.84%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $8,833,000 USD 49%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,323,000 USD 26%
Operating Lease, Payments $100,000 USD -80%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $600,000 USD -2.6%
Deferred Tax Assets, Net of Valuation Allowance $4,936,000 USD 21%
Share-based Payment Arrangement, Expense $46,115,000 USD 33%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%